INTERNATIONAL PATENT: BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD. FILES APPLICATION FOR "ANTI-CD276 ANTIBODY, ANTIBODY-DRUG CONJUGATE AND USE THEREOF"

GENEVA, Jan. 17 -- BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD. (Building 7, Hexiang Technology Center, Qiantang AreaHangzhou, Zhejiang 310018) filed a patent application (PCT/CN2024/105037) for "ANTI-CD276 ANTIBODY, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF" on Jul 11, 2024. With publication no. WO/2026/011391, the details related to the patent application was published on Jan 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): XIA, Bing (Building 7, Hexiang Technology Center, Qiantang AreaHangzhou, Zhejiang 310018), CAO, Lixia (Building 7, Hexiang Technology Center, Qiantang AreaHangzhou, Z...